A Case Report and Literature Review of Babesiosis-Induced Acute Respiratory Distress Syndrome

Table 1

Cases and case series of babesiosis-inducedARDS.

	Case	Age (years)/gender	Antibabesia therapy to ARDS (days)	Parasitemia (%)	Died	Comorbidities
Gordon et al.	1	79/F	5	10	Yes	Perforated diverticulitis
Iacopino et al.	2	63/F	2	12	No	Not available
Horowitz et al.	3	70/M	3	2	No	Not available
Boustani et al.	4	65/F	2	15	No	Lyme disease
	5	40/M	1	1	No	HTN, Lyme disease
	6	74/M	Unknown	0.1	No	Lyme disease
Panduranga et al.	7	59/M	N/A	<1	No	HTN, HLD, Afib
Stowell et al.	8	25/F	2	20	No	Splenectomy for HS, seizure, hypothyroidism, depression
Alvarez De Leon et al.	9	36/M	N/A	0.05	No	SSD, HC, cirrhosis
	10	72/F	1	15	Yes	HTN, DM
	11	53/F	4	12.8	No	HTN, UTI
	12	55/M	2	10	No	Splenectomy
	13	54/F	N/A	4	No	Asthma
	14	75/F	4	0.5	No	HTN, CLL
	15	69/M	2	4.7	Yes	HTN, CKD
	16	81/F	1	0.5	Yes	HTN, CAD, asthma

Note. N/A, not applicable as the patient developed ARDS before antibabesia therapy. Abbreviations: ARDS, acute respiratory distress syndrome; F, female; M, male; HTN, hypertension; HLD, hyperlipidemia; Afib, atrial fibrillation; HS, hereditary spherocytosis; SSD, sickle cell disease; HC, hemochromatosis; CLL chronic lymphocytic leukemia; DM, diabetes mellitus; UTI, urinary tract infection; CKD, chronic kidney disease; and CAD, coronary artery disease.